Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

May Tun Saung

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0698-0092; OpenAlex author ID A5056721725. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper

Papers 7

  1. CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. First author DOI 10.1084/jem.20211631↗
  2. CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma. First author DOI 10.1016/j.canlet.2020.11.041↗
  3. Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer. First author DOI 10.1136/jitc-2019-000351↗
  4. Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-18-4192↗
  5. Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model … Co-author DOI 10.21037/apc.2019.11.01↗
  6. Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer. Co-author DOI 10.1186/s40425-018-0435-6↗
  7. Current Standards of Chemotherapy for Pancreatic Cancer. Co-author DOI 10.1016/j.clinthera.2017.08.015↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Zheng · 7 shared papers, 2017–2022 · strength 0.87
  2. Stephen T. Muth · 5 shared papers, 2018–2022 · strength 0.53
  3. Alex B. Blair · 4 shared papers, 2018–2021 · strength 0.41
  4. Ding Ding · 3 shared papers, 2018–2022 · strength 0.29
  5. Kenji Fujiwara · 2 shared papers, 2020–2022 · strength 0.20
  6. Brian T. Herbst · 2 shared papers, 2020–2022 · strength 0.20
  7. Keyu Li · 2 shared papers, 2020–2022 · strength 0.20
  8. Jin Peng He · 2 shared papers, 2019–2022 · strength 0.20
  9. Lisa M. Coussens · 2 shared papers, 2018–2019 · strength 0.16
  10. Takahiro Tsujikawa · 2 shared papers, 2018–2019 · strength 0.16
  11. Elizabeth M. Jaffee · 2 shared papers, 2018–2019 · strength 0.16
  12. Sophia Y. Chen · 1 shared paper, 2022 · strength 0.12
  13. Nan Niu · 1 shared paper, 2022 · strength 0.12
  14. Jianxin Wang · 1 shared paper, 2022 · strength 0.12
  15. Noah S Rozich · 1 shared paper, 2022 · strength 0.12
  16. Jun-Ke Wang · 1 shared paper, 2022 · strength 0.12
  17. Yao Xu · 1 shared paper, 2022 · strength 0.12
  18. Amol Kumar Narang · 1 shared paper, 2022 · strength 0.12
  19. Noelle R. Jurcak · 1 shared paper, 2020 · strength 0.09
  20. Annie A. Wu · 1 shared paper, 2020 · strength 0.09
  21. Elaine O. Bigelow · 1 shared paper, 2020 · strength 0.09
  22. Victoria Kim · 1 shared paper, 2019 · strength 0.08
  23. Richard Andrew Burkhart · 1 shared paper, 2019 · strength 0.08
  24. Christopher L. Wolfgang · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.